Pay in 4 interest-free payments of $5.60 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Tirzepatide: Dual-Action Weight Loss Therapy Tirzepatide, found in Zepbound, works on two hormone receptors: GLP-1 (appetite and satiety) GIP (glucose-dependent insulinotropic polypeptide), which plays a role in insulin sensitivity and fat metabolism This dual-action approach often leads to: Greater appetite suppression Enhanced effects on blood sugar regulation Higher average weight-loss outcomes in many patients Because tirzepatide influences more than one metabolic pathway, it may be particularly beneficial for individuals with insulin resistance or metabolic syndrome
This suggests that when joint discomfort occurs, it's often linked to secondary factors rather than semaglutide's direct action on GLP-1 receptors
Reference: Alpert A J, Gilbert H F
H.KimE.-J.SeoB.-K.HongS.-U.et al (2022)
Louis Share the resources below to raise awareness about compounded GLP-1 drugs
FDA Alerts Health Care Providers, Compounders and Patients of Dosing Errors Associated With Compounded Injectable Semaglutide Product
